Recent Updates
Recently added Catalysts
GRAL Positive Sentiment Score: 65/100

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company...

Wednesday, December 18, 2024 1 min read
Key Takeaway: GRAIL, Inc. will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th. The event is significant for the company as it aims to showcase its advancements in early cancer detection. Management's presentation is expected to highlight GRAIL's mission and innovations. Investors can access live and archived webcasts from the event on the company's investor relations page.

Market Sentiment Analysis

POSITIVE FACTORS

  • GRAIL is focusing on early cancer detection, enhancing patient outcomes.
  • Presence at a prestigious conference increases visibility and credibility.
  • Opportunity to engage with investors and share innovation updates.

Full Press Release Details

MENLO PARK, Calif. , Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL ), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15 at 9:00 a.m. PT .
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com . The webcast will be archived and available for reply for at least 30 days after the event.
For more information, visit grail.com .
SOURCE GRAIL, Inc.

21 %

Frequently Asked Questions

When will GRAIL present at the J.P. Morgan Healthcare Conference?

GRAIL will present on January 15, 2024, at 9:00 a.m. PT.

How can I access the GRAIL conference webcast?

You can access the webcast at investors.grail.com in the investor relations section.

Will the GRAIL webcast be available after the live event?

Yes, the webcast will be archived and available for replay for at least 30 days.

What is GRAIL's mission?

GRAIL aims to detect cancer early when it is most treatable.

Tags: GRAL Viatris Investor Conferences Healthcare GRAIL cancer detection J.P. Morgan Healthcare Nasdaq: GRAL healthcare conference
Last updated: Dec 18, 2024